ILD-PRO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Jan 2026)
What this means for you
Registered since 14 Jul 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88695562
- Registration number
- 6099852
- Mark type
- Stylized text
- Filed
- 17 Nov 2019
- Published for opposition
- 28 Apr 2020
- Registered
- 14 Jul 2020
- Attorney of record
- Scott J. Major
Goods and services
- Class 035 — Advertising and business services: Maintaining registries of patients with interstitial lung diseases; promoting awareness of interstitial lung diseases, their symptoms, prevention and treatment, and promoting awareness of biomarker testing therefor
- Class 044 — Medical, beauty and agricultural services: Providing medical and pharmaceutical information regarding interstitial lung diseases, their symptoms, prevention and treatment, and providing medical information regarding biomarker testing relating thereto
Owner
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prosecution history
- 08 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 14 Jul 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jul 2020 — REGISTERED-PRINCIPAL REGISTER
- 28 Apr 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Apr 2020 — PUBLISHED FOR OPPOSITION
- 08 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Mar 2020 — ASSIGNED TO LIE
- 14 Mar 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Mar 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Mar 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED